The companies said they will submit their data by the end of the week and ask the F.D.A. to approve a third shot.The companies said they will submit their data by the end of the week and ask the F.D.A. to approve a third shot.Vaccination and Immunization, Coronavirus (2019-nCoV), Clinical Trials, Coronavirus Risks and Safety Concerns, BioNTech SE, Pfizer Inc, Moderna Inc, Food and Drug Administration, United StatesRead More
